Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 1 ... Tissue Regeneration, Transplantation, Treatment, U.S. Food and Drug Administration, BioMimetic Therapeutics Inc. This article was prepared by Medical Letter on the CDC & FDA editors from ...
2009 NOV 16 ... Technology, Therapy, Tissue Engineering, Treatment, U.S. Food and Drug Administration, BioMimetic Therapeutics Inc. This article was prepared by Biotech Business Week editors from staff and ...
2009 APR 20 ... who now owns and markets that product.
Keywords: Therapy, Treatment, BioMimetic Therapeutics Inc.
This article was prepared by Biotech Business Week editors from staff ...
2009 JUN 29 ... Investment, Marketing, Nanotech, Sports, Stock Market, TechnologyTherapy, Treatment, BioMimetic Therapeutics Inc.
This article was prepared by Biotech Business Week editors from staff ...
2009 JUL 6 ... Investment, Marketing, Nanotech, Sports, Stock Market, TechnologyTherapy, Treatment, BioMimetic Therapeutics Inc. This article was prepared by Biotech Business Week editors from staff and ...
2009 MAY 4 ... of Inflammatory Bowel Disease (IBD). Vysera Biomedical has developed its own proprietary biomimetic material enabling minimally invasive treatment of gastroesophageal reflux disease ... is a Professor of Clinical Pharmacology and Head of the Department of Pharmacology & Therapeutics of the National University of Ireland, Galway. He will be presenting on Regulation of ...
2009 MAR 23 ... will provide bio-assay analyses and sophisticated visualization capabilities for BioMimeticTherapeutics, Inc. (NASDAQ: BMTI) through SAS Visual Data Discovery for Midsize ...
2008 OCT 6 ... Autograft, Bone, Clinical Trial Research, Pain Medicine, Surgery, Therapy, Treatment, BioMimetic Therapeutics Inc.
This article was prepared by Pain & Central Nervous System Week editors ...
2008 JUL 14 ... Pharmaceuticals, Surgery, Surgical Technology, Therapy, Tissue Engineering, Treatment, BioMimetic Therapeutics Inc.
This article was prepared by Biotech Business Week editors from staff ...
2008 NOV 10 ... Reaction, Bone, Clinical Trial Research, Radius Fractures, Surgery, Therapy, Treatment, BioMimetic Therapeutics Inc.
This article was prepared by Biotech Business Week editors from staff ...
2008 AUG 25 ... drug-device convergence and pain management. He currently serves on the boards of BioMimetic Pharmaceuticals (NASD: BMTI), Carbylan BioSurgery, Follica, KAI Pharmaceuticals, Solace ... is a board member of Alvine Pharmaceuticals, Primera Diagnostics, Sequel, Inc. and Trius Therapeutics. Kjellson played a primary role in InterWest's investment in Aspreva Pharmaceuticals ...
2008 JUL 14 ... The overarching goal of this research is to utilize these multidomain peptides as a biomimetic scaffold, along with dental stem cell therapy, to provide a natural 3D environment that ... with failure rates of up to 60%. Hence, there exists a critical need for better biologic therapeutics to restore the damaged dentin-pulp complex to its original form and function. However, ...
Subject: International & American Association for Dental Research
